167 related articles for article (PubMed ID: 10737576)
1. Extent of resection in the management of duodenal adenocarcinoma.
Kaklamanos IG; Bathe OF; Franceschi D; Camarda C; Levi J; Livingstone AS
Am J Surg; 2000 Jan; 179(1):37-41. PubMed ID: 10737576
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes in patients with duodenal adenocarcinoma.
Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
[TBL] [Abstract][Full Text] [Related]
3. Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?
Sakamoto T; Saiura A; Ono Y; Mise Y; Inoue Y; Ishizawa T; Takahashi Y; Ito H
Ann Surg Oncol; 2017 Oct; 24(11):3368-3375. PubMed ID: 28799027
[TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
5. What prognostic factors are important in duodenal adenocarcinoma?
Bakaeen FG; Murr MM; Sarr MG; Thompson GB; Farnell MB; Nagorney DM; Farley DR; van Heerden JA; Wiersema LM; Schleck CD; Donohue JH
Arch Surg; 2000 Jun; 135(6):635-41; discussion 641-2. PubMed ID: 10843358
[TBL] [Abstract][Full Text] [Related]
6. Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection.
Lowell JA; Rossi RL; Munson JL; Braasch JW
Arch Surg; 1992 May; 127(5):557-60. PubMed ID: 1349472
[TBL] [Abstract][Full Text] [Related]
7. Duodenal adenocarcinoma: Surgical results of 27 patients treated at a single center.
López-Domínguez J; Busquets J; Secanella L; Peláez N; Serrano T; Fabregat J
Cir Esp (Engl Ed); 2019 Nov; 97(9):523-530. PubMed ID: 31563268
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of radical resection for locally advanced duodenal adenocarcinoma.
Bucher P; Gervaz P; Morel P
Hepatogastroenterology; 2005; 52(66):1727-9. PubMed ID: 16334766
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
10. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
11. Surgery for Duodenal Gastrointestinal Stromal Tumors: A Single-Center Experience.
Chen P; Song T; Wang X; Zhou H; Zhang T; Wu Q; Kong D; Cui Y; Li H; Li Q
Dig Dis Sci; 2017 Nov; 62(11):3167-3176. PubMed ID: 28914399
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic invasion as the prognostic indicator of duodenal adenocarcinoma treated by pancreatoduodenectomy plus extended lymphadenectomy.
Ohigashi H; Ishikawa O; Tamura S; Imaoka S; Sasaki Y; Kameyama M; Kabuto T; Furukawa H; Hiratsuka M; Fujita M; Hashimoto T; Hosomi N; Kuroda C
Surgery; 1998 Sep; 124(3):510-5. PubMed ID: 9736903
[TBL] [Abstract][Full Text] [Related]
13. Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases.
Cloyd JM; Norton JA; Visser BC; Poultsides GA
Ann Surg Oncol; 2015 Feb; 22(2):573-80. PubMed ID: 25160736
[TBL] [Abstract][Full Text] [Related]
14. The surgical treatment and outcome for primary duodenal adenocarcinoma.
Han SL; Cheng J; Zhou HZ; Zeng QQ; Lan SH
J Gastrointest Cancer; 2009; 40(1-2):33-7. PubMed ID: 19513860
[TBL] [Abstract][Full Text] [Related]
15. The surgical treatment and outcome for primary duodenal adenocarcinoma.
Han SL; Cheng J; Zhou HZ; Zeng QQ; Lan SH
J Gastrointest Cancer; 2010 Dec; 41(4):243-7. PubMed ID: 20431961
[TBL] [Abstract][Full Text] [Related]
16. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.
Poultsides GA; Huang LC; Cameron JL; Tuli R; Lan L; Hruban RH; Pawlik TM; Herman JM; Edil BH; Ahuja N; Choti MA; Wolfgang CL; Schulick RD
Ann Surg Oncol; 2012 Jun; 19(6):1928-35. PubMed ID: 22167476
[TBL] [Abstract][Full Text] [Related]
17. Outcome after surgical resection for duodenal adenocarcinoma in the UK.
Solaini L; Jamieson NB; Metcalfe M; Abu Hilal M; Soonawalla Z; Davidson BR; McKay C; Kocher HM;
Br J Surg; 2015 May; 102(6):676-81. PubMed ID: 25776995
[TBL] [Abstract][Full Text] [Related]
18. Surgical morbidity, mortality, and long-term survival in patients with peripancreatic cancer following pancreaticoduodenectomy.
Stephens J; Kuhn J; O'Brien J; Preskitt J; Derrick H; Fisher T; Fuller R; Lieberman Z
Am J Surg; 1997 Dec; 174(6):600-3; discussion 603-4. PubMed ID: 9409581
[TBL] [Abstract][Full Text] [Related]
19. The surgical treatment and outcome for primary duodenal adenocarcinoma.
Han SL; Cheng J; Zhou HZ; Zeng QQ; Lan SH
J Gastrointest Cancer; 2008; 39(1-4):46-50. PubMed ID: 19399645
[TBL] [Abstract][Full Text] [Related]
20. Primary duodenal adenocarcinoma: a 40-year experience.
Ryder NM; Ko CY; Hines OJ; Gloor B; Reber HA
Arch Surg; 2000 Sep; 135(9):1070-4; discussion 1074-5. PubMed ID: 10982512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
